HESI RN
HESI RN D441 Pharmacology 0A1 Questions
Extract:
Question 1 of 5
To control asthma, a client in a residential treatment facility uses a fluticasone propionate and salmeterol discus inhalation system, which provides an inhaled powdered form of these combined medications. Which instruction should the nurse provide to this client's caregivers?
Correct Answer: D
Rationale: Fluticasone propionate and salmeterol discus is a maintenance medication used twice daily to control asthma. Caregivers should ensure adherence to this schedule and not use it for acute attacks, which require a rescue inhaler.
Question 2 of 5
The nurse is planning the home care of a client who is receiving a mydriatic medication. Which environment is best for this client?
Correct Answer: A
Rationale: Mydriatic medications dilate pupils, increasing light sensitivity. A dimly lit room reduces glare and discomfort, making it the best environment for the client’s comfort.
Question 3 of 5
A client with chemotherapy-induced nausea receives a prescription for metoclopramide. Which adverse effect is most important for the nurse to report?
Correct Answer: B
Rationale: Metoclopramide can cause extrapyramidal symptoms like involuntary movements (e.g., tardive dyskinesia), which are serious and may require medication adjustment or discontinuation. This adverse effect is more critical to report than diarrhea, irritability, or nausea.
Question 4 of 5
A client with eczema receives a prescription for betamethasone cream. Which client statement indicates to the nurse that further teaching is needed?
Correct Answer: B
Rationale: Covering the site with an occlusive dressing can increase betamethasone absorption and side effects, and should only be done under specific medical guidance. This statement requires further teaching to ensure safe use.
Question 5 of 5
A client with anemia secondary to chronic kidney disease (CKD) started a prescription for epoetin alfa two months ago. Which client finding best indicates that the medication is effective?
Correct Answer: D
Rationale: The most direct indicator of the effectiveness of epoetin alfa is an increase in hemoglobin levels. Epoetin alfa stimulates erythropoiesis, raising hemoglobin in clients with anemia due to CKD. Monitoring hemoglobin provides objective evidence of the medication’s efficacy, unlike subjective reports or dietary changes.